Cite
HARVARD Citation
Bassetti, M. et al. (n.d.). 1271. Efficacy and Safety of Cefiderocol and Best Available Therapy in Patients with Serious Infections Caused by Carbapenem-Resistant Gram-Negative Infections: Results of the Pathogen-Focused Phase 3 CREDIBLE-CR Study. Open forum infectious diseases. pp. S652-S653. [Online].